-
1 Comment
Exelerate Capital Corp is currently in a long term uptrend where the price is trading 10.9% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Exelerate Capital Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 37.3% to $-40K since the same quarter in the previous year.
Finally, its free cash flow fell by 354.4% to $-20K since the same quarter in the previous year.
Based on the above factors, Exelerate Capital Corp gets an overall score of 3/5.
| CurrencyCode | CAD |
|---|---|
| ISIN | None |
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | V |
| PE Ratio | None |
|---|---|
| Dividend Yield | None |
| Market Cap | 527K |
| Beta | 0.99 |
Exelerate Capital Corp. does not have significant operations. It intends to identify and evaluate businesses or assets with a view to complete a qualifying transaction. The company was formerly known as Exelerate Health Inc. and changed its name to Exelerate Capital Corp. in February 2019. Exelerate Capital Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for XCAP-P.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
